KNS-760704
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KNS-760704, covering 2021-07-08 to 2021-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) [Phase 2]